Edwards Lifesciences Corporatio vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.2
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
EW
Clean balance sheet with low leverage (0.1× debt-to-equity).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $97.15 (+15.7%)
27 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
EW
JNJ
45.4×
Trailing P/E
26.3×
25.0×
Forward P/E
17.9×
17.4%
Profit Margin
21.8%
77.9%
Gross Margin
68.0%
—
ROE
26.4%
16.7%
Revenue Growth
9.9%
8.2%
Earnings Growth
-52.9%
0.94
Beta
0.33
—
Price / Book
—
$48.4B
Market Cap
$546.9B
$72 – $88
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →